View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
All bar one of the suspended drugs contain the NSAID flunixin. The other affected drug is the antibiotic, Tribrissen:
Allevinix 50 mg/ml Solution for Injection for Cattle, Pigs and Horses (Ceva Animal Health)
Cronyxin Injection, 5% w/v Solution for Injection, for cattle and horses (Cross Vetpharm Group Ltd)
Finadyne 50 mg/ml Solution for Injection for cattle, pigs and horses (Intervet UK Ltd)
Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs (Norbrook Laboratories Limited)
Meflosyl 5% Solution for Injection for horses and cattle (Zoetis UK Limited)
Norixin 5% Solution for Injection for cattle and horses (Norbrook Laboratories Limited)
Pyroflam 50 mg/ml Solution for Injection for Cattle, Horses and Pigs (Norbrook Laboratories Limited)
Tribrissen 48% Suspension for Injection for horses, pigs and cattle (Intervet UK Ltd)
The British Equine Veterinary Association says that the decision to suspend the drugs was taken without consultation with the veterinary profession, and is urging the VMD to overturn the suspension in horses not destined for the human food chain, to reduce the potential impact on equine welfare.
Jonathan Pycock, BEVA president said: "BEVA is fully supportive of all attempts to promote food safety, however flunixin is widely viewed as the gold-standard pain killer in horses and is commonly used in horses undergoing both elective and emergency surgery, for the crippling pain associated with laminitis and for severe forms of colic.
"BEVA is calling on the VMD to immediately enable limited batch release of flunixin for use in horses not destined for the human food chain in the interests of animal welfare. The equine veterinary profession has always been open to consultation with the VMD on a range of important matters relating to responsible medicine use, antibiotic resistance, horse identification, passports and the horse meat issue. BEVA is perplexed as to why the VMD failed to consult with the equine veterinary industry on the animal welfare impact of withdrawing such an important drug.”
NEV was first identified in 2013 by veterinary surgeon Dr Isabel Fidalgo Carvalho, who went on to found Equigerminal to develop a commercially viable NEV diagnostic test that can be used by veterinary surgeons, vet labs and horse owners.
Isabel says that NEV - the equine equivalent of HIV - is often misdiagnosed or hidden by other diseases that induce similar symptoms, like anaemia and neurological issues in horses. It is most commonly confused with the Swamp Fever virus (EIAV) and Equine Herpesviruses (EHV).
Indeed, when they tested a number of horses with anaemia, Equigerminal researchers first believed they had found the presence of a divergent strain of the Swamp Fever Virus (EIAV) - because the horses cross reacted with EIAV, but were negative in the official tests. Subsequent research found they were actually suffering from NEV.
Equigerminal says it is believed that NEV is present in up to 10% of horses. Isabel said: "We did test 213 samples from Ireland and found 7% of positive samples for NEV. These Irish horses were horses that usually travel to UK and other locations for sports events."
For the new test, a veterinary surgeon needs to take a blood sample which is sent to the Equigerminal lab.
Isabel says treatment is currently targeted towards improving the general well-being of the horse, health monitoring, and boosting the animal’s immune system. The next stage is to find a treatment, and ideally a cure for NEV. Meantime, Isabel said: “We now need to raise awareness of the problem and help vets to diagnose this disease correctly.”
Bovalto Respi Intranasal protects against the two main respiratory viruses – RSV and PI3, using modified live viral strains that have been shown to protect against experimental challenge from recent field isolates1.
The vaccine is delivered as a single shot, from 10 days of age and provides immunity for 12 weeks, from 10 days after vaccination2.
In order to overcome the challenges of effective delivery, Boehringer is offering dedicated administration packs, available directly from its ruminant specialist team.
The packs include a vaccinator, a set of nozzles that deliver the vaccine at the optimum droplet size and a soft Bovalto Respisafe applicator which fits against the calf’s nostril. The aim is to make sure that vaccination is a comfortable process for both farmer and calf, as well as addressing the challenge of the delivery of vaccine to the desired area in the nasal passages.
Correct administration of the vaccine ensures that the spray is delivered effectively to the mucosal surface and local lymphoid tissue, achieving the optimal immune response. If the droplet size is too big, the vaccine may be deposited lower in the airway and run out of the nose. If droplet size is too small then the vaccine may be carried to the back of the throat and swallowed. Time and money is spent vaccinating calves so the process needs to be as efficient as possible to give optimal protection.
Matt Yarnall, brand manager at Boehringer Ingelheim said: "The UK BRD vaccine market is growing each year but, as a management tool, vaccination remains quite low down the list of actions, according to the 2017 Calfmatters survey.
"If adding to the Bovalto range encourages more farmers to vaccinate against pneumonia so improving calf heath and lowering antibiotic use, that can only be a step in the right direction."
References
Equine glandular gastric disease is a complex syndrome that is distinct from gastric ulceration. A number of studies now indicate that it is an inflammatory gastritis, predominantly at the gastric outflow, which has different causes and risk factors from gastric ulcers. As such, medication effective in treating gastric ulceration may be less effective for this specific condition.
The clinical signs of EGGD are diverse and non-specific and may be mild or recurrent. They may include changes in temperament, changes in rideability, unexplained weight loss, reduced appetite or cutaneous sensitivity manifesting as biting of the flanks or resentment of girthing, grooming, leg aids or rugging. Recommendations for reducing the prevalence of disease, based on putative risk factors, include providing rest days from work, maximising turn-out, minimising management changes and other potential stress factors and minimising changes in equine companions and human carers.
The new guidelines have been published by a group of equine medicine specialists, based on a review of published and unpublished evidence. The intention is to provide veterinary practitioners with up-to-date guidance on risk factors, diagnosis, treatment, dietary management and prevention of EGGD.
David Rendle, an internal medicine specialist at Rainbow Equine Hospital in North Yorkshire who chaired the group and is a consultant editor of UK Vet: Equine said: "Our findings challenge long-standing dogma on EGGD, a condition about which there is currently very little advice available to vets and horse owners. It is becoming increasingly clear that the distinction between disease of the squamous and glandular mucosa is important clinically and the group felt that updated guidance may help to improve management of EGGD in practice."
Provision of evidence based clinical guidelines should enable practitioners to adopt more standardised and logical approaches and base EGGD management decisions on the most current data.
Professor Josh Slater, Professor of Equine Clinical Studies at the Royal Veterinary College said: "Clinical guidelines are commonly used in human health care and have been shown to improve clinical outcomes by condensing data from large numbers of research publications and promoting rapid adoption into clinical practice. These new guidelines represent a step forward in the management of this complex condition by combining a consensus of expert opinion with the best available current clinical research and evidence."
Mark Bowen, Professor of veterinary internal medicine at the University of Nottingham who is based at Oakham Veterinary Hospital said: "Whilst the panel hasn’t come up with miracle cures there was universal agreement that new treatment options have to be integrated in a logical and responsible manner."
"Our understanding of this condition is in its infancy but we hope that the summary document, which also highlights the gaps in our knowledge, will provide a useful framework for vets to follow and will be a stimulus for future research."
The guidelines can be found here: https://www.magonlinelibrary.com/doi/full/10.12968/ukve.2018.2.S1.3
Photo: Marked multi-focal depressed haemorrhagic and fibrinosuppurative lesions
IMV says it has acquired BCF to widen its offering in the reproduction management sector, particularly in imaging. As part of this strategy the company acquired ECM, a French veterinary ultrasound manufacturer, last June, and has launched AlphaVision, a video-assisted bovine insemination system.
Alan Picken, Managing Director of BCF, will lead the imaging division of IMV Technologies and become a member of the Management Board of the Group.
Philippe Gravier, Chief Executive Officer of IMV Technologies, said: "For over 50 years, IMV has been at the forefront of innovations in animal artificial insemination and embryo transfer. Following the acquisition of ECM earlier this year, the integration of BCF supports our vision to supply health status and reproduction-readiness tools to veterinarians, breeding technicians and livestock owners.
"I am very excited that BCF is joining the IMV Technologies Group. Our 100 employees have worked hard to build this company to where it is now. There is no doubt that IMV’s strong brand, customer loyalty and extensive distribution network will help to expand further our imaging activities. Like IMV, I share the vision that market differentiation is in supporting customers to improve animal care, achieved through constant innovation and marketing leading products and services."
The charge against Ms Law was that in November 2017, having performed surgery on Kiwi, a German Shepherd/Wolfhound-cross dog, to address gastric dilation volvulus (GDV), she failed to obtain informed consent to the entirety of the surgical process and management, including post-operative aftercare.
The charge also stated that she failed to provide adequate analgesia to Kiwi before, during or after the surgery, failed to provide appropriate and adequate fluid therapy to Kiwi, failed to offer an appropriate and adequate post-operative care plan and/or post-operative transfer for Kiwi to another practice and failed to inform the owners that there would be nobody present at the practice to provide post-operative monitoring and aftercare for Kiwi for approximately seven hours during the night.
Finally the charge stated that Ms Law allowed Kiwi to remain at the practice overnight from 12:30am to 07:45am without adequate monitoring or post-operative aftercare.
Ms Law admitted some of the charges against her, including that she had failed to obtain informed consent, failed to offer an appropriate and/or adequate post-operative care plan, failed to inform the owners that there would be nobody present at the practice and allowed Kiwi to remain at the practice overnight without adequate monitoring and/or post-operative aftercare. However, she denied that she failed to provide adequate analgesia or fluid therapy to Kiwi.
The Committee found all of the charges proved, with the exception of failing to provide adequate analgesia during the perioperative period.
Having considered the facts, the Committee then moved on to consider whether the admitted and proven charges against Ms Law amounted to serious professional misconduct, taking into account any aggravating and mitigating factors. The aggravating features were that, as a result of Ms Law’s failures in relation to analgesia and fluid therapy, there was either actual injury to Kiwi, or a risk of such injury.
In mitigation, the Committee considered that she promptly and accurately diagnosed GDV, and proceeded to perform the necessary emergency surgery. The Committee considered that the charges related to a single isolated incident and that Ms Law has had an unblemished career to date. They also noted that Ms Law had made open and frank admissions as to the majority of the charges.
The Committee found that the conduct of Ms Law set out in the majority of the charges did not amount to serious professional misconduct. However, in the judgement of the Committee, Ms Law’s conduct in allowing Kiwi to remain at the practice overnight without adequate monitoring or post-operative aftercare did amount to serious professional misconduct.
Jane Downes, who chaired the Committee and spoke on its behalf, said: "The Committee considers that the respondent (Ms Law) has insight into the serious mistake that she made in failing to ensure that Kiwi was checked or monitored overnight. The Committee has found that this was a single isolated incident, which involved a serious lapse of clinical judgement, which will probably stay in the mind of the respondent for the rest of her career.
"The respondent has been in practice for some nine years now, and apart from this incident, there is no suggestion that the respondent has fallen short of the standards expected of her on any other occasion. The Committee does not consider that there is a risk that the respondent is likely to leave an animal overnight after major surgery again, without ensuring that it is checked during that time, and, as such, the Committee considers that there is no future risk to the welfare of animals so far as the respondent is concerned."
The Committee considered that the finding of disgraceful conduct in a professional respect in this case is too serious for no further action to be taken, having regard to the need to maintain public confidence in the profession and declare and uphold proper standards of conduct.
The Committee therefore concluded that the appropriate sanction in this case was to issue a reprimand to Ms Law, in relation to the finding of serious professional misconduct.
Jane Downes added: "The Committee considers that this sanction, coupled with the findings of fact and disgraceful conduct made against the respondent, is sufficient to maintain public confidence in the profession and uphold proper standards of conduct. The Committee does not consider it necessary to issue a warning to the respondent about her future conduct, on the basis that the Committee has concluded that there is no risk of repetition."
There were three charges against Ms Creese, all pertaining to the period between July 2016 and November 2017.
The first charge was that she failed to ensure that there were adequate systems and processes in place for out-of-hours’ care for in-patients.
The second charge was that she publicised that the practice had "24 hour care provided by our vets at our practice" and/or "Care 24/7 for your pets" on its website, which suggested that staff were present at the practice 24 hours a day when they were not and as such publicity was dishonest and/or misleading.
The third charge against Ms Creese was that she failed to ensure that Kiwi's owners were informed about arrangements at the practice for out-of-hours’ care for in-patients.
At the outset of the hearing, Ms Creese denied all the charges against her.
After hearing evidence from relevant witnesses, the Committee considered that the practice did have in place systems and processes for out-of-hours care for in-patients and that there was no evidence of repeated or ignored failures of these systems and processes. The Committee therefore found the charges against Ms Creese not proved and all three were dismissed.
The petition was set up by veterinary surgeon and journalist Pete Wedderburn, after discussion with colleagues, in response to an open letter to the profession from Jemima Harrison, producer of the Pedigree Dogs Exposed documentary broadcast in 2008.
In the letter, Jemima notes that Kennel club registrations of Pugs rose from 2,000 in 2005 to 10,000 last year. Over the same period Bulldog registrations more than doubled to 7,000 and the number of French Bulldogs increased 4000% to 14,607.
All vets do, she says, is 'organise CPD days on how to manage the increasing numbers of creatures that turn up at your practice doors gasping for air', 'refer clients on to soft-tissue specialists who do their best to remedy the deformity that has been bred into them', and 'section that Bulldog and say nothing to the breeder about how wrong it is that the dogs are no longer capable of birthing their own pups'.
She argues that there is 'institutional kow-towing to the Kennel Club and a reluctance to do anything other than accept their platitudes that they have to take things slowly or risk "losing" the breeders'.
In response, Pete's blog and petition calls for a working party to develop concrete proposals to tackle the issues as a matter of urgency: 'Despite the evident appeal of short-nosed pets to many of our clients, it is our duty as vets to not just treat these animals, but also to lobby for reform in the way they are bred – in particular the 'extreme' brachycephalics such as Pugs, Bulldogs, French Bulldogs and flat-faced Persian cats'.
The Dog Breeding Reform Group has welcomed the petition. Chris Laurence MBE, DBRG Trustee and former veterinary director of the Dogs Trust who has signed the petition, says: "Vets in companion animal practice see dogs with inherited breathing difficulty almost every day and are frustrated that there seems to be no end to the daily suffering of these breeds. The DBRG is delighted that vets are now getting together to highlight the issue and to plead with breeders to stop producing puppies with such malformed heads that they are unable to breathe easily."
The petition, which has already gathered nearly 1000 signatures, can only be signed by veterinary surgeons and nurses. You can sign it here.
Animalcare has launched Buprecare into the UK and Ireland veterinary markets. Buprecare (POM-V) is a veterinary licensed analgesic, containing buprenorphine, for use in dogs and cats. It is licensed for post-operative analgesia in dogs and cats, and potentiation of the sedative effect of centrally acting agents in dogs.
This is the second major product the company has introduced in the last 18 months as Animalcare continues to grow its portfolio of veterinary products with the launch of an ACE inhibitor Benazecare (benazepril hydrochloride) earlier in 2007.
To complement the product launch, Animalcare is offering an ampoule breaker to help practice staff to open ampoules safely, together with a practice support package, containing pain scoring pads to aid in the assessment of pain of patients and judging of adequate analgesia requirements. In addition a dosing table and poster detailing common behavioural changes that can be associated with pain are available. Buprecare 0.3mg/ml is available in 1ml ampoules, in cartons of 5 ampoules.
Stephen Wildridge, Managing Director of Animalcare Ltd. said: "We have a very exciting time ahead with the launches of several new pharmaceutical products over the next twelve months, and the proposed expansion of our business into the major European veterinary markets."
Please contact your Animalcare representative, or ring 01904 487687 for more details.
The Codes of Professional Conduct for both veterinary surgeons and veterinary nurses stress the need for effective communication with clients and ensuring that informed consent is obtained and documented before treatments or procedures are carried out.
At its January meeting RCVS Standards Committee approved changes to chapter 11 (‘Communication and consent’) of the supporting guidance to the Codes to provide further advice to the professions on matters that should be discussed with clients to ensure informed consent is gained, provide clarification on who can gain consent for a procedure and give some additional guidance on consent forms.
Nick Oldham, Standards and Advisory Manager at the RCVS, said: "We hope that this updated guidance is more accessible, readable and will aid members of the profession in developing a more comprehensive approach to gaining informed consent for treatments and procedures and therefore reduce the risk of miscommunication and misunderstanding which can lead to concerns being raised by clients.
"For example, we have updated our guidance to encourage veterinary surgeons to consider discussing a number of additional factors with a client before obtaining consent. This includes the nature, purpose and benefits of any treatment or procedures, the likely outcomes including potential risks, financial estimates, informing the client when other treatments may have available and checking that the client understands what they are agreeing to rather than assuming the client understands both the potential financial outlay and possible side effects.
"Furthermore, there is now additional guidance for veterinary surgeons on who should be seeking consent. While ordinarily it is expected that the veterinary surgeon undertaking the procedure or providing treatment is responsible for obtaining the client’s consent we know that this is not always practical.
"Therefore we clarify that the responsibility of obtaining consent can be delegated to another veterinary surgeon and, failing that, a registered veterinary nurse or student veterinary nurse could obtain consent provided that they are suitably trained, have sufficient knowledge of the proposed procedure or treatment and understand the risks involved.
"The RCVS Standards and Advice Team is also in the process of producing a series of fictional case studies based on informed consent issues encountered by the College’s Preliminary Investigation Committee which we hope will further help the profession."
The updated supporting guidance can be found in full at www.rcvs.org.uk/consent
The Code of Professional Conduct and its supporting guidance can also be downloaded as an app for smartphones and tablets at www.rcvs.org.uk/codeapp
Members of the profession seeking confidential advice on matters relating to professional conduct can contact the Standards and Advice Team on 020 7202 0789 or advice@rcvs.org.uk
Fort Dodge Animal Health has launched PropoClear, a short-acting, intravenous general anaesthetic for dogs and cats.
The company believes that PropoClear, based on novel lipid-free micro-emulsion technology, will deliver significant clinical benefits over conventional lipid-based propofol emulsions, and will also deliver increased cost-effectiveness and convenience to practices.
PropoClear is indicated for use as a short-acting general anaesthetic for procedures lasting up to five minutes. It is also indicated for the induction and maintenance of general anaesthesia using incremental doses and for the induction of anaesthesia where maintenance is provided by inhalation.
According to Fort Dodge, PropoClear's unique lipid-free, nano-emulsion formulation and its inclusion of antimicrobial preservatives provide the following key benefits to practices:
Dr Jo Murrell, Department of Clinical Veterinary Science, Division of Companion Animals, the University of Bristol, said: "With currently available lipid-based propofol formulations unused drug should be discarded immediately once the vial has been opened leading to drug wastage or the potential for bacterial contamination of the remaining solution if this regulation is ignored. The new lipid-free propofol formulation, which also contains antimicrobial preservatives, overcomes this limitation and will provide significant clinical benefits in terms of the 28 day shelf life once broached."
Matthew Rowe, Marketing Manager for Companion Animals at Fort Dodge, said: "In developing PropoClear, it was our goal to deliver an anaesthetic product with the same proven efficacy as the existing solution but which offered significant benefits in terms of enhanced safety, cost and convenience.
"PropoClear contains the same concentration of the established active molecule and follows familiar guide dose protocols to ensure ease of use. We have been encouraged by the positive feedback received during product trials and believe the significant advantages its offers, both clinically and financially, to practices in challenging times, will ensure its rapid adoption by veterinary practices across the UK."
16 clinics are affected by the investigation, namely Penrose Veterinary Group Limited, Kevin Castle (Pet Care) Ltd, Swayne & Partners Ltd, Treforest Veterinary Clinic Ltd, Mercer & Hughes Limited, Swaffham Veterinary Centre Limited, Anglesey Pet Clinic Ltd, Chiltern Equine Clinic.
It's not the first time, of course, that the CMA has intervened in the veterinary profession.
Earlier this year, it investigated the acquisition of Quality Pet Care (trading as The Vet) by CVS, and then Vet Partners' acquisition of Goddards, which led to CVS selling The Vet and Vet Partners selling eight of the 47 Goddards sites to Linnaeus.
An IVC spokesperson said: “IVC Evidensia is working closely with the CMA and engaging constructively with this review."
Bayer has introduced a new microchip scanner which is capable of reading all chips, including encrypted ones.
The company says the new Tracer Advance Isomax V scanner offers exceptional reading distances of more than twice those of other scanners on the market, making it a very versatile tool ideally suited for use in companion animal practices or for detecting microchips in larger animals such as horses.
The technology that gives this scanner its backward compatibility with non ISO standard chips means practices can now save money by only having to buy one scanner, whereas previously two were required to be able to read all types of chip.
Other features of the device include digital signal processing (DSP), which protects against radio interference from TVs and PCs, and connectivity via USB, RS232 or optional Bluetooth interface.
The Tracer Advance Isomax V scanner is available from Bayer and is priced at £499.95. It comes with a 30-month warranty. Contact your Bayer territory representative for further details.
Nerfasin vet is available in two concentrations - a 100 mg/ml (10%) solution for cattle and horses and 20 mg/ml (2%) solution for cattle, horses, cats and dogs.
Nerfasin vet is on sale in 25 ml vials.
For more information visit: www.dechra.co.uk.
The hearing took place in Mr Prichard's absence after he failed to respond to Colleges attempts to contact him, including by email, post, telephone and personal service of documents.
However, in its decision to proceed in Mr Prichard’s absence, the Committee confirmed that it would not hold his non-attendance against him or attach any adverse inference to that fact.
Mr Prichard was charged with taking quantities of the controlled, prescription-only drug Vetergesic from the practice’s stock other than for legitimate veterinary use.
He was further charged that he took Vetergesic from the practice by drawing it into a syringe for the purposes of self administration, and that in doing so, his conduct was dishonest.
In another set of charges, it was alleged that on five separate occasions, Mr Prichard had attended the practice to work as a veterinary surgeon whilst unfit to do so.
The final charge related to Mr Prichard’s failure to respond adequately or at all to all reasonable requests from the RCVS for his response to concerns raised about his conduct.
At the beginning of the hearing Nicole Curtis, acting on behalf of the College, read the written evidence from 11 separate witnesses outlining the facts related to the charges against Mr Prichard, including the record of an investigative meeting held by the practice in which he admitted his theft and use of the controlled drug and following which, he was dismissed from his employment.
The Committee found all the charges proven and then considered whether they amounted to serious professional misconduct.
In terms of aggravating factors the Committee found that there was a risk of injury, recklessness, premeditated and sustained misconduct, and that there was an abuse of his professional position in accessing prescription-only controlled drugs for reasons other than legitimate veterinary use.
In mitigation, the Committee considered that he had made admissions as part of the practice’s internal disciplinary investigation.
Overall, the Committee found he had breached aspects of the Code of Professional Conduct related to honesty and integrity, making animal health and welfare his first priority, appropriate use of veterinary medicines, taking steps to address physical and mental health conditions that could affect fitness to practise, responding to reasonable requests from the RCVS, and bringing the profession into disrepute.
Therefore, the Committee found him guilty of serious professional misconduct in relation to all of the charges charges.
The Committee felt that, considering the seriousness of the misconduct, removal from the Register was the most appropriate decision.
Austin Kirwan, chairing the Committee and speaking on its behalf, said: “This is a case involving serious dishonesty, sustained over a period of time, and conduct potentially detrimental to animal welfare, as well as wilful disregard of professional regulations.
“Regrettably, Mr Prichard’s failure to engage with the College and with the regulatory process limited the options open to the Committee.
"Notwithstanding this, Mr Prichard’s disgraceful conduct is so serious that removal from the Register is the only means of protecting animals and the wider public interest which includes the maintenance of public confidence in the profession and the upholding of standards.”
www.rcvs.org.uk/disciplinary
The figures highlight the burden placed on veterinary surgeons every day when they're asked to euthanise perfectly healthy animals.
Problem behaviours include persistent barking and howling, destructive chewing and inappropriate toileting. Aggressive behaviour, towards both people and other pets, is also a problem, with the PDSA Animal Wellbeing (PAW) report revealing that a third of pet owners have been attacked or bitten by a dog. Such behaviours can cause a breakdown of the human-animal bond, leading to pets being excluded from family life to the detriment of their welfare, relinquished to rehoming centres or euthanised.
The BVA says these figures overwhelmingly show the importance of adequate socialisation of animals at an early age – young animals should safely encounter a variety of people, animals and everyday household sights and sounds in their first few weeks and months of age, beginning at the place where they are born.
Other reasons that owners give their veterinary surgeon for wanting to euthanise a healthy pet included: poor health of the owner (48%), owners moving to accommodation that is unsuitable for their pet (39%), and legal enforcement reasons (32%).
British Veterinary Association President Sean Wensley said: "These figures are stark and are likely to come as a shock to members of the public. But this is the sad reality of a failure to socialise animals from the earliest possible age – a specific time in a puppy’s development which has a significant impact on their future temperament and behaviour. With dogs, this process starts from before a puppy is even seen by a potential owner. In recent months there has been a litany of news stories about the illegal importation, breeding and trading of puppies through puppy farms. This is no way for a family pet to start life and we urge potential owners to thoroughly research where a puppy has been born and reared, using the AWF/RSPCA Puppy contract to help. Then, in the first year of ownership, and especially in the first few weeks, work with your local veterinary practice to ensure your puppy is introduced to everyday sights and sounds, including other people and animals, in a safe and structured way."
Mr Wensley also commented on the impact on vets: "Nobody enters the veterinary profession wanting to euthanise healthy pets, but this is the stressful situation that many vets are facing because of undesirable behaviours in pet animals. Vets will do all they can in these situations to avoid euthanasia, including offering evidence-based behavioural advice, referring to accredited pet behaviourists or assisting with rehoming through reputable rehoming organisations, but sometimes these options are not appropriate, particularly where the behavioural issues make it extremely difficult to rehome the animal. Vets are not required to euthanise healthy animals at an owner’s request, but sometimes, having carefully considered all options and given the circumstances the pet finds themselves in, it may be in an animal’s best interests to do so. Euthanising an animal who could have been a loving pet is the hidden, tragic cost of poor socialisation."
Credelio Plus is a palatable, chewy, monthly tablet which contains milbemycin oxime for the control of the gastrointestinal nematodes: hookworm (L4, immature adult (L5) and adult Ancylostoma caninum), roundworms (L4, immature adult (L5) and adult Toxocara canis and adult Toxascaris leonina) and whipworm (adult Trichuris vulpis). Also for the prevention of angiostrongylosis by reduction of the level of infection with immature adult (L5) and adult stages of Angiostrongylus vasorum (lungworm) with monthly administration. Also for the prevention of heartworm disease (Dirofilaria immitis).
Credelio Plus also contains lotilaner for the immediate and persistent treatment of ticks (Dermacentor reticulatus, Ixodes ricinus, Rhipicephalus sanguineus and I. hexagonus) and flea (Ctenocephalides felis and C. canis) infestations in dogs.
Credelio Plus is licensed for puppies as young as 8 weeks and weighing 1.4 kg or more.
Tina Hunt, General Manager of Elanco UK/Ireland said: "The launch of Credelio Plus represents another exciting evolutionary leap for Elanco’s parasiticide portfolio.”
Cat Henstridge MRCVS, otherwise known as 'Cat the Vet' said: "As a companion animal vet, one of the common challenges I see from pet owners is the need to remember and administer multiple treatments to cover a variety of parasites.
"So a simple, easy-to-remember treatment will be welcomed by my clients who need a combination solution to protect their dogs from ticks, fleas and worms.”
To mark the launch of Credelio Plus, Elanco is inviting vets and nurses to register for an online event at which the astronaut Major Tim Peake will talk about the lessons he’s learnt about leadership and teamwork, performing in high-pressured environments and the future of medicine and science. He'll be followed by Cat Henstridge, who will give a presentation about the power of wider veterinary teams working ‘better together’ to support each other, and how practices can start to reconnect with their clients following lockdown.
Lepha McCartan, BVetMed MRCVS, Veterinary Technical Consultant, Elanco Animal Health, will also speak about Elanco’s ongoing work within the parasite space. There will also be a live Q&A where attendees can put questions to the panel.
To sign up for the launch event, visit https://www.myelanco.co.uk/brand/credelio-plus-launch-registration
Dogs with RVED develop retinal degeneration from around four years of age which, if untreated, leads to blindness.
In partnership with James Oliver, Head of Ophthalmology at DWR Veterinary Specialists (pictured), researchers set out to discover why some Cocker Spaniels have such low vitamin E levels in their blood, despite it being present at normal amounts in their diet
James helped to design the study, recruit cases and collect samples.
Cathryn Mellersh, Senior Research Associate at the Canine Genetics Centre, said: “The team strongly suspected a genetic cause and has been trying to discover the responsible gene for several years with the help of owners and vets, who have contributed DNA samples.
“Thanks to updated information on the canine genome, Katherine Stanbury, one of our research associates, found a mutation in the alpha tocopherol transfer protein gene which is causative of the disease.
“This gene is responsible for getting vitamin E into the blood stream.
"We now know that RVED is a recessive disease, meaning that affected dogs must have two copies of the faulty gene to develop low vitamin E levels and retinal degeneration.”
The team’s DNA test can be used by dog breeders to find out if dogs carry the gene mutation, so they can avoid matings which result in affected puppies being born.
Cathryn said: “This DNA test is a rare example of one which not only can be used to identify dogs that are carrying the mutation and thus reduce the frequency of the mutation in future generations, but also has the incredible benefit of providing a sight-saving treatment option for dogs with the disease.
“From the research we have done we estimate that there could be several hundred Cocker Spaniels alive today that have two copies of this mutation, whose eyesight could be saved by this test.”
A DNA test for the mutation that causes RVED is now available from Canine Genetics Testing, which operates alongside researchers from the Canine Genetics Centre.
www.cagt.co.uk.
The team’s RVED research can be viewed at https://academic.oup.com/g3journal/advance-article/doi/10.1093/g3journal/jkaf016/7985679?searchresult=1
The Disciplinary Committee heard that Mr Samuel had been convicted of five animal welfare offences at Leeds Magistrates' Court in January 2016. The charges related to causing unnecessary suffering to a number of animals including twelve dogs and four cats, and failing to take steps to ensure that the needs of the animals for which he was responsible were met. The animals were kept at the Armley Veterinary Practice, for which Mr Samuel was, at the time, practice principal.
Mr Samuel was sentenced to 12 weeks' imprisonment suspended for 12 months on the condition he completed 150 hours' unpaid work and paid a fine of £100. He was also ordered to pay costs of £500 and a victim surcharge of £80. He was also made subject to a disqualification order for three years.
Dr Samuel subsequently appealed against his conviction in April 2018. His appeal was dismissed in respect of five of the charges but was upheld in respect of one charge, which, as a result, did not form part of the College’s case.
Dr Samuel declined to attend the hearing in person and was not represented before the Disciplinary Committee. In considering the facts of the charges against Dr Samuel the Committee found them proven.
The Committee then went on to consider whether the proven charges, both individually and cumulatively, rendered Dr Samuel unfit to practise as a veterinary surgeon.
The College’s case was that the convictions concerned animal welfare and therefore went to the heart of his practice as a vet, that Dr Samuel behaved in a manner incompatible with being a veterinary surgeon, that he failed in his core responsibility as a veterinary surgeon to protect and act in the best interests of animal welfare, and that he maintained he had no responsibility for the animals on his practice premises – an assertion referred to as ‘an extraordinary position for a veterinary surgeon to take’.
Ian Green, chairing the Committee and speaking on its behalf, said: "ust as the judgment of the Crown Court and the Magistrates Court had found, the Committee also found that Dr Samuel must have known that the animals were in distress and were in a neglected state. The Committee was sure that Dr Samuel must have been aware of the animals notwithstanding his continued denial. The Committee concluded that Dr Samuel was unfit to practise because of the facts underlying the convictions. Dr Samuel had an overriding duty of care for the animals and to take action in relation to their health and welfare because they were living under the roof of his veterinary practice."
In considering its sanction against Dr Samuel, the Committee concluded that removal from the Register was the most appropriate option. It took into account the fact that the animals were found starving in a cellar without water, that Dr Samuel had not demonstrated insight into the serious nature of his offences, that he continued to deny responsibility and, furthermore, found no evidence that he no longer posed a risk to animals in the future.
Ian Green added: "The Committee decided that the behaviour found proved was fundamentally incompatible with being a veterinary surgeon because in this case there had been a serious departure from standards as set out in the RCVS Code of Professional Conduct for Veterinary Surgeons…. Furthermore, there had been serious harm caused to a number of animals and a risk of harm to a number of other animals."
Dr Samuel has 28 days from being informed of the Disciplinary Committee’s decision in which to make an appeal to the Privy Council.
The Committee’s full decision and findings can be found here
The Disciplinary Committee, chaired by Mr Stuart Drummond, considered six charges against Dr Gunn.
The first charge alleged that, early in 2018, Dr Gunn failed to provide appropriate and adequate care to the dog. In particular, having removed a mass from the right thorax, he undertook an excess number of surgical procedures, including under general anaesthetic, within a 13 day period; performed these procedures without offering alternative treatments or discussing referral with the owners; failed to recognise infected wounds; and administered an antibiotic when the dog was infected with MRSA and E-coli.
The second charge alleged that Dr Gunn failed to communicate adequately, openly and honestly with the owners of the terrier on multiple occasions between 16 January and 3 February 2018. This included but was not limited to: failing to provide the owners with an estimation of fees; failing to inform them in advance of the procedures performed; failing to inform them of options for treatment; and failing to inform them that the terrier had an infection when he knew or ought to have known that she did.
The third charge alleged that Dr Gunn failed to obtain informed consent in relation to the further procedures performed on the terrier in charge one.
The fourth charge alleged that Dr Gunn failed to maintain adequate clinical records in relation to the management of the dog, and that he failed to record the prescription and administration of drugs to treat the terrier.
The fifth charge alleged that Dr Gunn indicated to the owners that euthanasia was the most appropriate treatment option and/or that there were no other realistic treatment options, when this was not the case and when he ought to have known this was not the case.
The sixth charge alleged that, during the course of a referral of the terrier to another practice, Dr Gunn failed to provide an adequate history of his management of the dog and that he informed the practice that the owners had no finances when this was not true, amounting to an incomplete account of his dealings with the owners and to a breach of their confidence.
At the outset of the hearing the respondent admitted to a number of the allegations within the main six charges, which were found proved by the Committee.
Of the charges not admitted to, a number were found proved and the Committee then went on to consider whether or not Dr Gunn’s conduct amounted to serious professional misconduct.
In considering the aggravating factors, the Committee took into account that the dog’s suffering was prolonged because of the persistence of Dr Gunn in pursuing a single ineffective treatment approach.
With regards to mitigating factors, the Committee found that Dr Gunn was remorseful as to his actions, that there was no financial motivation on the part of Dr Gunn in respect of his treatment of the terrier, and that there is a low risk of repetition because Dr Gunn has sought to learn from this experience. A number of relevant and high-quality testimonials were also provided by colleagues and many satisfied owners on behalf of Dr Gunn.
Considering both the aggravating and mitigating factors, the Committee was satisfied that Dr Gunn’s conduct fell far below the standard expected of a registered veterinary surgeon for a number of the charges.
The Committee then considered what sanction to impose on Dr Gunn. The Committee was satisfied that the misconduct found proved was in relation to the treatment of one dog only and therefore it was at the lower end of the spectrum. However, the conduct took place over a prolonged period of two weeks which in the Committee’s view required a sanction. In such circumstances, and with the significant mitigation, the Committee decided that the appropriate and proportionate sanction was to reprimand Dr Gunn and to warn him about his future conduct.
Speaking on behalf of the Committee, Mr Stuart Drummond said: "The Committee concluded that the effect of a reprimand alongside the Committee’s findings on disgraceful conduct in a professional respect was a sufficient and proportionate sanction. The Committee found Dr Gunn to have developed sufficient insight into his failings and it was satisfied that the disciplinary process had been a salutary experience and that he is very unlikely to pose a risk to animals in the future or to contravene professional standards.
"The Committee decided that a warning as to future conduct was necessary to reduce the risk of any repetition of any similar conduct for Dr Gunn in the future. It therefore concluded that the sanction of a reprimand and warning would be a sufficient in the circumstances of this case having taking into consideration all the powerful personal mitigation."
The complete list of charges and the Committee’s full facts and findings can be found at www.rcvs.org.uk/disciplinary
32% said they find dog care to be too restrictive
29% said it would be too difficult to go on holiday
24% said they don’t want to walk the dog every day and 25% that having a dog is too expensive.
41% of those who said they regret getting a dog bought it during lockdown.
Davies says the new treatment is appropriate for dogs with severe diffuse elbow dysplasia, where cartilage wear results in bone rubbing against bone, called medial compartment disease (MCD). In these cases, Davies says that the prognosis is typically poor but now CUE is providing a promising alternative surgical option when arthroscopic and non-surgical options have failed.
The surgery involves partial resurfacing of the elbow joint. By focusing on the specific area of disease in the medial compartment, the CUE implant provides a less invasive bone-sparing option for resurfacing the bone-on-bone medial compartment while preserving the dog’s own good cartilage in the lateral compartment. Davies says that in most dogs, the technique significantly improves the pain and lameness that was caused by bone-on-bone grinding.
Unlike total elbow replacements, CUE does not require major bone cutting. On average, recovery tends to be significantly faster with progressive improvement peaking six months after surgery.
Mike Farrell, EBVS European and RCVS Specialist in Small Animal Surgery (Orthopaedics) at Davies recently performed a successful CUE procedure on Rubee, an 11-year-old Labradoodle diagnosed with severe MCD. At the recheck, six weeks after surgery Mike said: "Rubee’s early response to CUE has been nothing short of astonishing. I would have been pleased if she had made the improvement seen today after six months rather than six weeks."
Louise Clark Head of Anaesthesia and the Pain Clinic at Davies Veterinary Specialists continued: "CUE potentially provides a surgical alternative for what is currently an incredibly frustrating condition to manage and one that causes animals a lot of pain, and owners a great deal of angst.
"Arguably it is an ethically robust procedure because it can dramatically reduce patient pain with a relatively well defined risk of complications in a patient cohort that is otherwise at risk of euthanasia because of elbow disease."
For more information, visit: https://vetspecialists.co.uk/services/orthopaedics/
RIP Fleas, the environmental flea treatment from Genitrix, has been given a new formulation to ensure it acts more quickly in the killing of adult fleas and that it continues to kill fleas as they emerge from pupae for up to 12 months.
Now known as RIP Fleas Extra, the product is also licensed for the control of house dust mites in the environment for up to 12 months.
According to Genitrix, the reformulation makes RIP Fleas Extra the only environmental flea treatment to contain three active ingredients while complying fully with new EU Biocides regulations. It is the only such treatment to be fragranced and is also the only product to be presented in a volume which will cover 120 square metres – ie the size of an average house. RIP Fleas Extra contains:
Tetramethrin – a second generation synthetic pythrethroid and a contact insecticide with a rapid knockdown action of insect pests
Permethrin – a potent insecticide with a powerful contact action on insects but with a low toxicity to most mammals
Methoprene – a compound that mimics the insect juvenile hormone and arrests development of fleas and house dust mites in the environment.
When used synergistically, Tetramethrin and Permethrin provide a rapid knockdown and kill of fleas as they hatch from pupae. Studies have shown that this combination works four times more quickly than Permethrin alone.
Dorset-based homeopathic practitioner Philippa Rodale, who requested that her name be removed from the RCVS Register in July, has been convicted of cruelty at Weymouth Magistrates Court.
The case related to Mrs Rodale's treatment of a female foxhound called 'Dangerous', which had been brought to her after being hit by a car.
The dog was reported to the RSPCA by a member of the public who was alarmed after seeing the dog lying in the surgery, whining and dragging her back legs. The court heard that at this point, Dangerous had already been in the care of the clinic for 10 days, during which time Mrs Rodale had administered both homeopathic and conventional treatment, but had failed either to x-ray the animal or give adequate pain relief. In addition, the court heard hygiene and nursing care standards were poor.
RSPCA inspector Marie Griffiths said: "When I found Dangerous she was just lying on a tiled floor with no bedding and only a towel propping up her head, paralysed, and covered in infected pressure sores. She couldn’t even stand up.
"It was a shocking sight and definitely not something that I would ever expect to see anywhere, let alone in a veterinary practice.
"She was clearly in agony and had just not received the level of care and attention that you would expect from a vet. She was suffering so much that sadly a decision had to be made by another veterinary surgeon to do the kind thing and finally put her to sleep.
"The RSPCA exists to protect animals from cruelty and suffering and to defend them when their needs are not being met and we hope that this case goes some way to showing that no-one is exempt from providing animals with the duty of care that they deserve - not only morally, but because it is also the law.”
Mrs Rodale was ordered to pay £4,000 in costs to the RSPCA as well as £520 in court charges and a £15 victim surcharge.
Do you think the RCVS should issue a public statement about homeopathy, and require that veterinary surgeons inform owners about the scientific evidence which demonstrates it is ineffective? If so, visit The Campaign For Rational Veterinary Medicine, and sign the petition.
Picture BNPS
Virtual Vet Derms has been set up to be able to give advice to veterinary surgeons on any aspect of skin or ear disease whether it is allergy, otitis media, cutaneous neoplasia or endocrine-based in any species, including dogs, cats, small furries, exotic pets including raptors, birds and reptiles, horses, camelids, zoo and farm animals.
Sue, herself an RCVS Recognised Specialist in Veterinary Dermatology, is supported by a team of veterinary dermatology colleagues as well as veterinary specialists in exotic medicine, internal medicine (including endocrinology) and consultants with expertise in oncology.
Sue said: "We recognise that not every veterinarian has got access to a local dermatology specialist and that not all clients can or want to travel to a referral centre. The aim of the service is to formalise the advice that dermatology clinicians give to veterinary surgeons to allow them to get detailed help to manage difficult or challenging dermatology cases within their own practice."
The service has been set up under the RCVS Vivet initiative, is approved by all of the major insurance companies and supported with Veterinary Defence Society Insurance cover.
Virtual Vet Derms offers support in a range of ways.
Quick questionsShort questions that veterinary surgeons can submit via the online form on the Virtual Vet Derms website that just require a brief reply. This may be a dose of a drug, a parasite you want identifying, or the interpretation of a blood sample such as an ACTH stimulation test.
Veterinary reportsVeterinary surgeons can use online request forms on the Virtual Vet Derms web site to submit a brief history of the animal and the problem and some good quality photos of the skin condition. There is also the ability to upload histopathology reports, blood samples and any other pertinent information. A detailed written report is sent back to the vet within 48 hours which will describe clinical signs, differential diagnoses, recommended diagnostic tests and treatment option where appropriate. Where possible, Virtual Vet Derms aims to pass the advice request to the nearest dermatologist but vets can ask for advice from any of its specialists.
Telemedicine consultationsFor new cases or for cases where initial advice has been sought, in the client's own primary care veterinary practice via the internet. The Virtual Vets Derms specialist can consult with the owner to provide even more specific advice and support. After each teleconsultation the Virtual Vet Derms specialist will produce a report in the same format as the veterinary report to allow the primary care veterinary surgeon to continue to manage the case more effectively.
Face to face consultationsCan also be arranged via the owner’s vet at the specialist's own practice if there is the need for more specialist investigation that may not be available in the primary care veterinary surgery. In these cases, the specialist will take on the direct care of the case and work with the owner and vet on the best course of action.
General advice Also possible if the vet wishes to direct an owner straight to Virtual Vet Derms.
For more information, visit: https://virtualvetderms.com